Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Yesafili (aflibercept-jbvf), an Interchangeable Biosimilar to Eylea

The U.S. Food and Drug Administration (FDA) has approved Yesafili (aflibercept-jbvf), an interchangeable biosimilar to Eylea (aflibercept). Aflibercept...

FDA Approves Opuviz (aflibercept-yszy), an Interchangeable Biosimilar to Eylea

The U.S. Food and Drug Administration (FDA) has approved Opuviz (aflibercept-yszy), an interchangeable biosimilar to Eylea (aflibercept). Aflibercept...

FDA Approves Benlysta (belimumab) Autoinjector for Children with Systemic Lupus Erythematosus

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a 200 mg subcutaneous route of administration of Benlysta...

ASCO: Survivors of Early Breast Cancer Can Successfully Attempt Pregnancy

Most survivors of stage 0 to III breast cancer who attempt pregnancy postdiagnosis are able to become pregnant and have a live birth, according to a study...

ASCO: HPV Vaccination Positively Affecting More Than Just Cervical Cancer Risk

Human papillomavirus (HPV) vaccination is associated with reduced odds of several types of HPV-related cancers, not just cervical cancer, according to...

Nationwide Prevalence of Stroke Up From 2011-2013 to 2020-2022

The prevalence of stroke increased from 2011-2013 to 2020-2022, according to research published in the May 23 issue of the U.S. Centers for Disease Control...

One in Nine U.S. Children Have Ever Been Diagnosed With ADHD

Diagnoses of attention-deficit/hyperactivity disorder (ADHD) in U.S. children continue to increase, with approximately one in nine having ever received...

Laekna Announces FDA Approval for the Phase III Clinical Trial Protocol of Afuresertib PLUS LAE001 for the Treatment of Prostate Cancer

SHANGHAI and WARREN, N.J., May 23, 2024. Laekna, Inc., a science-driven, clinical-stage biotechnology company, announced that the company has received...

Stroke Rates Are Rising, Especially Among the Young

The rate at which Americans under the age of 65 suffered a stroke rose by about 15% between 2011 and 2022, new government data shows. That was true even...

Costs, Side Effects Drive Folks to Quit New Weight-Loss Meds

Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from...

CDC Reports Second Dairy Worker Infected With Bird Flu

A second case of bird flu has been detected in another dairy worker, this time in Michigan, U.S. health officials reported Wednesday. The first case was...

'Moving Forward': Battling Parkinson's, He's Rowing His Way to Paralympic Games

For decades, Todd Vogt has been dedicated to the sport of rowing, believing he was in peak physical condition. Then, a series of symptoms began to emerge,...

New Results From Rilzabrutinib Phase 2 Study Show Potential to be First Advanced Oral Treatment for Moderate-to-Severe Asthma

Paris, May 22, 2024. Encouraging results from a phase 2 study showed that treatment with oral rilzabrutinib at both high dose and low doses led to a numerical...

Hospira Inc. Issues Voluntary Recall for Buprenorphine HCl Injection Carpuject Units and Labetalol HCl Injection Carpuject Units Due to Potential for Incomplete Crimp Seals

May 21, 2024 - NEW YORK, NY., Hospira, Inc., a Pfizer company (“Pfizer”), is voluntarily recalling the lots listed in the table below of Buprenorphine...

Does It Matter What You Eat or Drink Before Bed?

If you suddenly find yourself craving food or drink right before you head to bed, one expert suggests you steer clear of big meals and caffeine. "From...

Read more news...

Recently Added

Recently added consumer and prescribing information: Yesafili, Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan, Voydeya

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Yesafili Yesafili (aflibercept-jbvf) is a vascular endothelial growth factor (VEGF) inhibitor interchangeable biosimilar to Eylea indicated for the...
  • Opuviz Opuviz (aflibercept-yszy) is a vascular endothelial growth factor (VEGF) inhibitor interchangeable biosimilar to Eylea indicated for the...
  • Imdelltra Imdelltra (tarlatamab-dlle) is a first-in-class, bispecific delta-like ligand 3 (DLL3)-directed CD3 T cell engager indicated for the...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development